Blazsek I - Search Results

1

Pathobiology of myelodysplastic syndromes.

Blazsek I, Mathé G. Blazsek I, et al. Biomed Pharmacother. 1990;44(2):69-83. doi: 10.1016/0753-3322(90)90108-l. Biomed Pharmacother. 1990. PMID: 2224058 Review.

2

Combined differentiation therapy in myelodysplastic syndrome with retinoid acid, 1 alpha,25 dihydroxyvitamin D3, and prednisone.

Blazsek I, Musset M, Boulé D, Labat ML, Bringuier MF, Comisso M, Le Maignan C, Ribaud P, Mathé G, Misset JL. Blazsek I, et al. Cancer Detect Prev. 1992;16(4):259-64. Cancer Detect Prev. 1992. PMID: 1458517

3

Retinoic acid in mono- or combined differentiation therapy of myelodysplasia and acute promyelocytic leukemia.

Blazsek I, Farabos C, Musset M, Goldschmidt E, Comisso M, Benavides M, Wang ZY, Labat ML, Mathé G, Misset JL. Blazsek I, et al. Biomed Pharmacother. 1991;45(4-5):169-77. doi: 10.1016/0753-3322(91)90104-2. Biomed Pharmacother. 1991. PMID: 1932600

4

Hematon, a multicellular functional unit in normal human bone marrow: structural organization, hemopoietic activity, and its relationship to myelodysplasia and myeloid leukemias.

Blazsek I, Misset JL, Benavides M, Comisso M, Ribaud P, Mathé G. Blazsek I, et al. Exp Hematol. 1990 May;18(4):259-65. Exp Hematol. 1990. PMID: 2182330

5

The differentiation-promoting potential of a cytostatic fluoro-pyranosyl adriamycin analog (FAD 104).

Blazsek I, Mathé G, Comisso M, Kitasato H, Umezawa K, Umezawa H. Blazsek I, et al. Biomed Pharmacother. 1989;43(4):267-70. doi: 10.1016/0753-3322(89)90007-3. Biomed Pharmacother. 1989. PMID: 2790148

6

Hematon: a multicellular functional unit in primary hematopoiesis.

Blazsek I, Misset JL, Comisso M, Mathé G. Blazsek I, et al. Biomed Pharmacother. 1988;42(10):661-8. Biomed Pharmacother. 1988. PMID: 3266080

7

Excess of lympho-reticular cell complexes in the bone marrow linked to T cell mediated dysmyelopoiesis.

Blazsek I, Goldschmidt E, Machover D, Misset JL, Benavides M, Comisso M, Ceresi E, Canon C, Labat ML, Mathé G. Blazsek I, et al. Biomed Pharmacother. 1986;40(1):28-32. Biomed Pharmacother. 1986. PMID: 3486680

8

Zinc and immunity.

Blazsek I, Mathé G. Blazsek I, et al. Biomed Pharmacother. 1984;38(4):187-93. Biomed Pharmacother. 1984. PMID: 6238634 Review.

9

Interleukins and immunosuppressive factors: a regulatory system?

Blazsek I, Mathé G. Blazsek I, et al. Biomed Pharmacother. 1983;37(6):258-65. Biomed Pharmacother. 1983. PMID: 6322876 Review.

10

Elliptinium, norcantharidin and tetrachlordecaoxide in combined chemo-immunotherapy prolong the survival of Friend-virus-infected mice.

Liu XH, Blazsek I, Breard J, Comisso M, Mathe G, Misset JL. Liu XH, et al. Among authors: blazsek i. Drugs Exp Clin Res. 1991;17(9):419-26. Drugs Exp Clin Res. 1991. PMID: 1822434

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters